news.cision.com

BillerudKorsnäs continues the development of the paper battery and has during the spring completed the world's first production on a paper machine. The project is thus a step closer to the commercialisation of both small and large-scale energy storage in a paper battery.In collaboration with researchers at Uppsala University, basic research has been developed to be able to use ordinary paper fibers for the manufacturing of batteries.The first production has now been carried out on a paper machine. This has been done at the dedicated pilot machine FEX at RISE, Research Institutes of Sweden.

Coor renews IFM agreement with Tieto in the Nordics

Coor has renewed its agreement with Tieto for the delivery of a large number of Integrated Facility Management (IFM) services in some 30 locations around Sweden, Norway and Denmark. The transaction, which is in the range of earlier agreements, spans a period of two years with the option of extending it further.The new agreement means Coor assuming total responsibility for coordinating, providing and developing a large range of FM services, including reception, conference services, fire safety & surveillance, mail & freight, switchboard, caretaker services, coffee & catering, cleaning, waste

Bioservo has entered distribution agreement for selling the all-new Ironhand® in France

Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) has entered an exclusive distribution agreement for selling the all-new Ironhand® with GOBIO, a brand of EUROPE TECHNOLOGIES Group, for the French market. Within EUROPE TECHNOLOGIES, GOBIO has a management team and sales forces in place that have already gained experience in successfully selling exoskeletons for industrial applications and are well connected with relevant customers in France that fit the Bioservo commercialization strategy. Petter Bäckgren, CEO Bioservo, commented: "We gladly welcome GOBIO to our broad set up in

TagMaster owned Balogh receives a further order on their new SIL 4 product platform

Press release, Stockholm, July 11, 2019 TagMaster, the leading supplier of advanced sensor systems for Smart Cities within Traffic and Rail, has, through its subsdiary Balogh SA, received an order for an American metro project. Balogh is one of the real pioneers in the RFID technology and was founded in 1958. Balogh today has offices for development and production in Paris, in Toulouse and in Normandie and works within the two RFID segments Rail and Access/Security (Traffic). The order comprises the new product range of MOS200/OMS201 (SIL4) products that have been finalized since

Trelleborg acquires engineering group and becomes a system provider for the fast-growing LNG transfer segment

Trelleborg has, through its Trelleborg Industrial Solutions business area, signed an agreement and finalized the acquisition of the engineering group Signum Technology Ltd. The group delivers safety critical solutions for flow control for the oil, gas and petrochemicals industries, such as marine breakaway couplings and LNG transfer systems. The acquisition complements and extends Trelleborg’s product portfolio and strengthens Trelleborg as a system provider, primarily to the fast-growing LNG transfer market segment. The group is headquartered in Wiltshire, England, with manufacturing in

Nordstjernan’s subsidiary Etac invests in HoverTech, a US patient handling company

Nordstjernan’s wholly-owned subsidiary Etac has made an investment in 70 percent of the shares in the US company HoverTech International (“HoverTech”). The investment strengthens Etac’s global position and will create a strong platform for further growth in Europe, the US and important export markets. Etac is a global supplier of mobility equipment and solutions used in home care, long term care and acute care. Etac’s sales in 2018 amounted to approximately SEK 1,750 million and the company has just over 900 employees. Etac’s products include manual wheelchairs, patient handling

Invitation to MIPS Capital Markets Day 2019

MIPS AB (“MIPS”) has the pleasure of inviting investors, financial analysts and media to the MIPS Capital Markets Day in Stockholm on September 20, 2019.During the Capital Markets Day, MIPS’ long-term strategy will be presented by Max Strandwitz, President and CEO, together with other members of the leadership team. The event will take place in Stockholm city on Friday the 20thSeptember 2019 between 10.00am and 1.00pm CET. The presentation will start at 10.00am and continue until 12.00pm CET. A light lunch will be served after the presentation. You can already now register to participate

Abu Dhabi orders 168 Volvo intercity coaches

Thu, Jul 11, 2019 08:55 CET

The Abu Dhabi Department of Transport (DoT) has ordered 168 premium intercity coaches from Volvo Buses and Famco Al Futtaim Auto & Machinery Co (Famco) through the city’s operators. The chassis order is the largest to date in Abu Dhabi for Volvo.Recently Volvo announced an order of 373 city buses for Dubai with the first deliveries in Q3, 2019. The Abu Dhabi Department of Transport has now ordered 168 premium intercity Volvo coaches from its operators. With the latest order, the Volvo fleet in the United Arab Emirates will amount to almost 800 vehicles, operating in all three segments in

Invitation – Presentation of Q2 2019 Interim Report

Boliden will announce its Interim Report for the second quarter 2019 on Friday 19 July at 07.45 (CET). A press and analyst conference will be held on the same day at 09.30, which also can be followed via webcast and telephone.The report will be presented by Boliden’s President and CEO Mikael Staffas, and CFO Håkan Gabrielsson. To participate, please call 5 minutes before the opening of the conference: · From Sweden +46 8 5199 9355 · From UK +44 20 319 40550 · From US +1 855 269 2605 The presentation will be live webcasted at www.boliden.com. For further information:

Follicum receives approval of patent in Korea

Thu, Jul 11, 2019 08:34 CET

Follicum AB (”Follicum”) today announces that the Korean patent office (”KIPO”) has approved the company’s patent application for stimulation of hair growth.With the approval in Korea, patent number 10-1992282, Follicum has a patent protection in Korean up to and including year 2032. The patent protects the company’s peptides in general and for stimulation of hair growth in particular. CEO Jan Alenfall comments- This patent approval is exciting as Korea is an important market for hair growth products. Other than the formal approval from Korea this patent has been approved in the US,

Eyeonid Group AB (publ) signs an exclusive cooperation agreement whit Sinew Software Systems Pvt Ltd regarding their Password Manager, Enpass

Thu, Jul 11, 2019 08:31 CET

Eyeonid Group AB (Eyeonid) have today signed an exclusive distribution- and cooperation agreement for the European market with Sinew Software Systems Pvt Ltd (Enpass) regarding their Password Manager (Product).As part of being able to offer the most complete and best service offering to our partners in what is called ID-security, Eyeonid have been evaluating several password managers for its customer friendliness as well as the technology behind to find and add such a module into Eyeonids customer offering. The Enpass Product is in fact more than a regular password manager where you as a

143% profitable growth and a successful integration of acquired technology

CELLINK publishes the quarterly report for the period 1st of March 2019 – 31st of May 2019 and for the first 9 months. The report is available on the company's website: http://cellink.com/investor-relations/. This press release presents a summary of the report. Third quarter · Net sales amounted to SEK 29,624 (12,202) thousand, corresponding to a growth of 143%, of which 109% was organic growth, compared to the third quarter of the previous fiscal year · Operating profit before depreciation (EBITDA) amounted to SEK 1,292 (1,044) thousand, corresponding to a margin of 4.4% (8.

Continued growth and strong cash flow

Summary of interim period, January–June 2019 · Net sales SEK 569.8 million (465.2) · EBITA SEK 125.3 million (94.7), with an EBITA margin of 22.0% (20.4) · Operating profit SEK 73.2 million (53.2), with an operating margin of 12.8% (11.4) · Profit after net financial items was SEK 67.8 million (48.1) · Earnings per share before dilution SEK 1.56 (1.29) · Cash flow from operating activities SEK 185.4 million (119.8) Summary of the period, April–June 2019 · Net sales SEK 290.8 million (242.8) · EBITA SEK 66.8 million (50.1), with an EBITA margin of 23.0% (20.6)

First Person Lightning Roulette and Dream Catcher join Evolution’s RNG games range

Evolution Gaming, leading provider of Live Casino solutions, has added two new titles — First Person Lightning Roulette and First Person Dream Catcher — to its range of online RNG games with integrated ‘Go Live’ functionality.Both of these First Person games are RNG-based versions of acclaimed and award-winning Evolution live games. The live dealer version of Evolution’s Lightning Roulette won three Game of the Year awards in 2018. The company’s Dream Catcher game, a spinning money wheel with a live presenter, was named Digital Product of the Year in the Global Gaming Awards at G2E Las

C-RAD to focus its sales resources on its core business going forward

C-RAD has decided to focus its sales activities on the current and upcoming new products and has therefore mutually agreed to terminate the distribution agreement with the Germany based company IBA Dosimetry GmbH. At the same time C-RAD will also expand its direct sales territory to the Baltic countries. C-RAD has distributed IBA Dosimetry products in the Nordic countries over the past almost ten years. The distribution agreement is terminated effective September 30, 2019. C-RAD will work closely with IBA to ensure a smooth transition of the customer relationship with regards to the

Reminder: Invitation to presentation of Orkla's second quarter 2019 results, Friday 12 July

Thu, Jul 11, 2019 08:27 CET

Orkla will report its second quarter 2019 results on Friday, 12 July at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com.The quarterly results will be presented at 8.00 a.m. at the Orkla House, Drammensveien 149, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at www.orkla.com or followed by telephone. Dial-in details: +47 21 03 33 94. Pincode: 1661193. To attend the presentation in Oslo, please register in advance by sending an email to: info@orkla.no. Please

Finavia’s airports had 12.8 million passengers in the first half of 2019

The first half of 2019 was busy at Finavia’s 21 airports. A total of 12.8 million passengers (+4.2%) travelled on scheduled and charter flights.In January-June, 10.6 million passengers (+5.0%) flew through Finland’s largest international hub, Helsinki Airport. At Finavia’s regional airports, the number of total passengers grew to 2.2 million (+0.3%). The amount of passengers grew the most at Rovaniemi Airport (+7.9%), Turku Airport (+7.4%) and Helsinki Airport. “At the same time as traffic continues to grow, we are doing significant construction and renovation work at Helsinki, Rovaniemi

Interim Report January-June 2019

Thu, Jul 11, 2019 08:15 CET

Second quarter 2019 compared to second quarter 2018 · Customer growth was 31,500 (23,300), an increase of 35 per cent · Net inflow in the quarter was SEK 8,270 million (4,840), an increase of 71 per cent · Operating income increased by 17 per cent, mainly due to improved net interest income but also higher brokerage income and fund commissions · Operating expenses increased by 8 per cent, mainly due to higher personnel cost. The long-term guidance on Avanza’s annual cost increase is 9−12 per cent, with a current budget figure for 2019 of 10.5 per cent · Net profit amounted

Second consecutive quarter with record series production

· Record annualised series production of 3.4 million Engine Equivalents in second quarter · Record annualised monthly production of 3.5 million Engine Equivalents in May · Installation revenue in second quarter surpasses previous full-year average[Stockholm, 11 July 2019] – Annualised series production reached 3.4 million Engine Equivalents in the second quarter of 2019, surpassing the previous record of 3.1 million Engine Equivalents set in the first quarter. Following two consecutive quarters of record series production, the annualised series production for the first half of 2019 is

Interim Report January – June 2019

BioArctic: Significant progress in the projects and additional milestone paymentSummary of key events for the second quarter 2019 · BioArctic received MEUR 15 milestone payment from Eisai for start of BAN2401 confirmatory Phase 3 study in early Alzheimer’s disease · Alzheimer’s Clinical Trials Consortium and Eisai announced that BAN2401 will be evaluated in a clinical study for prevention of Alzheimer’s disease · Ewa Björling was elected new member of the board at the Annual General Meeting · The Annual General Meeting approved the introduction of an employee warrant program

Orexo Interim Report Q2 2019

Improving all fundamentals Q2 2019 highlights · Total net revenues of SEK 201.2 million (199.7), up 0.8 percent and 19.1 percent when excluding ex-US milestone payment of SEK 30.8 million in Q2 2018 · Zubsolv® US net revenues of SEK 184.4 million (158.4), up 16.4 percent in SEK and 6.7 percent in local currency · EBITDA of SEK 60.4 million (50.6), up 19.4 percent · US EBIT of SEK 87.5 million (55.5), up 57.6 percent · Cash flow from operating activities of SEK 46.1 million (39.0), building a cash balance of · SEK 697.0 million (494.8) · Net earnings of SEK 54.6

Alligator Bioscience AB (publ) Interim report January-June 2019

Competitive safety data for ADC-1013.Significant events April-June• Janssen presented data from the clinical Phase I study with ADC-1013 indicates good safety and shows initial signs of clinical effect.• Study design and progress for the ongoing ATOR-1015 Phase I study showcased at ASCO.• Clinical trial authorization (CTA) application submitted to initiate a ATOR-1017 Phase I study.• New preclinical data presented at scientific conferences:- ATOR-1015:s tumor-localizing properties, shown with live-imaging technique, presented at PEGS (The Essential Protein Engineering Summit).-

Citycon H1/2019: Stable overall performance